Anti-CD23 Recombinant Antibody Lumiliximab(Lumiliximab) (CAT#: TAB-760)

Add to basket Submit an inquiry form Compare

• Gene Expression
• Datasheet
• MSDS
• COA

Normal Tissue

Figure 1 Bone marrow
(Hematopoietic cells
Staining: Medium
Intensity: Strong
Quantity: <25%
Location: Cytoplasmic/membranous)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/2624/6435_B_5_4.jpg

Figure 2 Lymph node
(Germinal center cells
Staining: High
Intensity: Strong
Quantity: 75%-25%
Location: Cytoplasmic/membranous
Non-germinal center cells
Staining: Medium
Intensity: Strong
Quantity: <25%
Location: Cytoplasmic/membranous)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/2624/6435_A_9_8.jpg

RNA Expression

Figure 3 RNA cell line category: Cell line enriched (HDLM-2)
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas v21.proteinatlas.org/ENSG00000104921-FCER2

 Datasheet

Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number

Specifications

Product Property

Target

Product Notes

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Lumiliximab"

Afuco™ Anti-CD23 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-760)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant chimeric (primate/human) antibody expressed in CHO. It is a monoclonal antibody that targets CD23. It acts as an immunomodulator. The drug is a chimeric antibody from Macaca irus and Homo sapiens.

DrugMonitor™ Anti-Lumiliximab Antibody (VS-1224-YC693)

Lumiliximab is a chimeric monoclonal antibody serving as an immunosuppressive drug, a primatized macaque/human anti-CD23 antibody for potentially treating allergic conditions. The DrugMonitor™ Anti-Lumiliximab Antibody (VS-1224-YC693) is an anti-drug antibody (ADA) against Lumiliximab. This drug-based antibody is raised in mice immunized with the Lumiliximab. The anti-Lumiliximab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Lumiliximab in samples.

See other products for "CD23"

Customer Reviews and Q&As

Popular products with customers

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.